-
November 17: Health Technology Assessment for Rare Diseases - In Person at ISPOR Europe 2024
-
November 17: Going Beyond the Standard: Exploring Advanced Survival Modeling Techniques - In Person at ISPOR Europe 2024
-
November 17: AI-Powered HEOR: Advancing Insights and Decisions with Large Language Models - In Person at ISPOR Europe 2024
-
ISPOR Real-World Evidence Summit 2024
, BARCELONA | SPAIN
This summit will cover latest developments in use of real world evidence across regulatory-HTA-payer decision-making continuum with focus on methods, data transportability, and infrastructure. Major methods topics to be covered include causal inference and external control arms for comparative effectiveness analyses, the hierarchy of RWE studies, and the role of patient registries. Use of RWE in Joint Clinical Assessment of the EU HTA regulation will be explored, also with insights from the cross-border collaborations on pricing and reimbursement in the EU countries. Finally, feasibility of HTA reassessment post market entry will be considered, drawing from lessons learned from US Medicare Drug Price Negotiation.
-
December 3: Primer on a 6-Step Approach to Budget Impact Analysis- Virtual
-
ISPOR Europe 2024-Digital Conference Pass
Join global healthcare leaders as they convene at ISPOR Europe 2024, the leading global conference for Health Economics and Outcomes Research (HEOR) in-person and virtually for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network in-person and virtually with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
-
December 4-5: Budget Impact Analysis II: Applications and Design Issues- Virtual
-
Leveraging the Value of Clinical Outcomes in DMD for Decision Making
-
MASLD/MASH: Clinical and Economic Findings from 40-year Follow-Up Data
-
February 12-13: Economic Model Review: Quality Control, Strategic Assessment and Reporting Standards - Virtual
-
Defining Patient-Facing DHIs With the PICOTS-ComTeC Framework
-
Impact of Delayed Patient Access to Cancer Treatment
-
Challenges in Defining Elements of Value in DMD for Decision Making
-
March 26-27: Introduction to Best Practices for Country Adaptations of Economic Models - Virtual
-
April 9-10: Introduction to Modeling - Virtual
-
Causal AI in HEOR: Beyond Predictions to Actionable Insights
-
April 23-24: Introduction to Machine Learning Methods - Virtual
-
ISPOR 2025
, Montreal | QC, Canada
Join global healthcare leaders as they convene at ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR) on May 13 - 16, for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
-
May 13: Advanced Patient-Reported Outcomes - In Person at ISPOR 2025
-
May 13: Using Nontraditional Digital Health Platforms: A Novel Source of Real-World Evidence - In Person at ISPOR 2025